Table 2. Distribution of the prevalence of metabolic syndrome and its components according to the height-for-age Z-scores at 2 years of age from the 1982 Pelotas cohort study (1982–2004).
Clinical and biochemical data |
<−2 |
⩾−2 |
||
---|---|---|---|---|
N | % | N | % | |
High fasting glucose (mg/dl) | 92 | 19.7 | 479 | 16.1 |
Low HDL (mg/dl) | 148 | 30.8* | 749 | 24.7 |
High triglycerides (mg/dl) | 60 | 12.5 | 536 | 17.6* |
High mean arterial pressure (mm Hg) | 142 | 26.4 | 821 | 24.1 |
High waist circumference (cm) | 22 | 4.3 | 218 | 6.6* |
Overweight (wt/ht2) | 38 | 5.5 | 339 | 8.0 |
Obesity (wt/ht2) | 7 | 1.0 | 46 | 1.1 |
Number of metabolic syndrome components presented | ||||
0 | 168 | 35.0 | 1247 | 40.7 |
1 | 200 | 41.7 | 1094 | 35.7 |
2 | 84 | 17.5 | 506 | 16.5 |
3 | 18 | 3.8 | 166 | 5.4 |
4 | 8 | 1.6 | 46 | 1.5 |
5 | 2 | 0.4 | 3 | 0.2 |
Metabolic syndrome | 28 | 5.8 | 215 | 7.0 |
Abbreviation: HDL, high-density lipoprotein.
χ2-test. Asterisks indicate statistical significance. *P-value<0.05.